Long 3 x 8 hr dialysis: a three-decade summary.

作者: Thierry Vanel , Cyril VoVan , Guillaume Jean , Charles Chazot , Jean-Claude Terrat

DOI:

关键词:

摘要: A long hemodialysis (HD), 3 x 8 hours/week, has been used without significant modification in Tassin for 35 years with excellent morbidity and mortality results. It can be performed during the day or overnight. The relatively good survival is mainly due to a lower cardiovascular than usually reported dialysis patients. This turn control of blood pressure (BP) including drug-free hypertension low incidence intradialytic hypotension. BP probably result tight extracellular volume normalization (dry weight), although one cannot exclude effect other factors such as serum phosphorus well achieved using dialysis. high dose small even more middle molecules another essential virtue dialysis, leading nutrition, correction anemia, phosphate potassium doses medications providing very cost-effective treatment. In 2002 must aim at optimal rather just adequate Optimal needs correct perfectly possible each every abnormality renal failure. longer (or frequent) sessions. Overnight most logical way implementing HD lowest hindrance on patient's life. Due change case mix decreasing number patients are able willing go overnight education autonomous difficult, but benefit still there.

参考文章(20)
Robert H. Barth, Short hemodialysis: big trouble in a small package Death on Hemodialysis: Preventable or Inevitable?. pp. 143- 157 ,(1994) , 10.1007/978-94-011-0806-5_14
M Wolfson, C J Strong, D Minturn, D K Gray, J D Kopple, Nutritional status and lymphocyte function in maintenance hemodialysis patients. The American Journal of Clinical Nutrition. ,vol. 39, pp. 547- 555 ,(1984) , 10.1093/AJCN/39.4.547
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
Bernard Charra, Edouard Calemard, Guy Laurent, Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. American Journal of Nephrology. ,vol. 16, pp. 35- 44 ,(1996) , 10.1159/000168968
E. G. Lowrie, N. M. Laird, T. F. Parker, J. A. Sargent, EFFECT OF THE HEMODIALYSIS PRESCRIPTION OF PATIENT MORBIDITY: REPORT FROM THE NATIONAL COOPERATIVE DIALYSIS STUDY The New England Journal of Medicine. ,vol. 305, pp. 1176- 1176 ,(1981) , 10.1056/NEJM198111123052003
Patrice Degoulet, Marcel Legrain, Isabelle Réach, Françoise Aimé, Claude Devriès, Patricio Rojas, Claude Jacobs, Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron. ,vol. 31, pp. 103- 110 ,(1982) , 10.1159/000182627
GA Block, TE Hulbert-Shearon, NW Levin, FK Port, Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study American Journal of Kidney Diseases. ,vol. 31, pp. 607- 617 ,(1998) , 10.1053/AJKD.1998.V31.PM9531176
Frank A. Gotch, John A. Sargent, A mechanistic analysis of the National Cooperative Dialysis Study (NCDS) Kidney International. ,vol. 28, pp. 526- 534 ,(1985) , 10.1038/KI.1985.160
Eberhard Ritz, Michael Schömig, Jürgen Bommer, Osteodystrophy in the millennium Kidney International. ,vol. 56, ,(1999) , 10.1046/J.1523-1755.1999.07314.X